1[1]Martucciello G,Bicocchi MP,Dodero P,et al.Total colonic aganglionosis associated with interstitial deletion of the long arm of chromosome 10[J].Pediatric Surg Int.1992; 7:308-310.
2[2]Lyonnet S,Bolino A,PeletA,et al.A gene for Hirschsprung disease maps to the proximal long arm of chromosome 10[J].Nat Genet.1993; 4:346-350.
3[3]Angrist M,Kauffman E,Slangenhaupt SA,et al.A gene for Hirschsprung disease in the pericentromeric region of human chromosome 10[J].Nat Genet.1993; 4:351-356.
4[4]Yin L,Ceccherini I,Pasini B,et al.Close linkage with the RET proto-oncogene and boundaries of deletion nutations in autosomal dominant Hirschsprung disease[J].Hum Mol Genet.1993; 2:1803-1808.
5[5]Ceccherini I,Bocciardi R,Yin L,et al.Exon structure and flanking intronic sequences of the human RET protooncogene[J].Biochem Biophys Res Commun.1993; 196:1288-1295.
6[6]Ceccherini I,Hofsrea RMW,Yin L,et al.DNA Polymorphisms and conditions for SSCP analysis of the 20 exons oh the RET proto-oncogene[J].Oncogene.1994; 9:3025-3029.
7[7]Attie T,Pelet A,Edery P,et al.Diversity of RET protooncogene mutations in familial and sporadic Hirschsprung's disease[J].Hum Mol Genet.1995; 4:1381-1386.
8[8]Treanor JJS,Goldman L,Sauvage F,et al.Characerization of a multicomponent receptor for GDNF[J].Nature.1996;382:80-83.
7Wang D,Luo M,Kelley MR.Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma:enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition[J].Mol Cancer Ther,2004,3(6):679-686.
8Munnes M,Fanaei S,Schmitz B,et al.Familial form of hirschsprung disease:nucleotide sequence studies reveal point mutations in the RET proto-oncogene in two of six families but not in other candidate genes[J].Am J Med Genet,2000,94:192-197.
9Julies MG,Moore SW,Kotze MJ,et al.Novel RET mutations in Hirschsprung's disease patients from the diverse South African population[J].Eur J Hum Genet,2001,9:419-423.
10Wang D, Luo M, Kelley MR. Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition [J]. Mol Cancer Ther, 2004, 3(6):679-686.
